Increased Insulin-like Growth Factor 1 Activity Can Rescue KLE Endometrial-like Cells from Apoptosis

Molecular Medicine

Volumn 7, Issue 1, 2001, Pages 20-26

  Koutsilieris, Michael ^a   Mastrogamvrakis, George ^a   Lembessis, Panayiotis ^a,b   Sourla, Antigone ^b   Miligos, Spyros ^a   Michalas, Stelios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Endo/OncoResearch Medical Laboratories   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; DOXORUBICIN; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; ASCITES FLUID; CELL CULTURE; CELL CYCLE; CELL DIVISION; DRUG EFFECT; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FLOW CYTOMETRY; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; ASCITIC FLUID; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; DNA FRAGMENTATION; DOXORUBICIN; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FLOW CYTOMETRY; HUMANS; INSULIN-LIKE GROWTH FACTOR I;

EID: 0035227666     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401835     Document Type: Article

References (49)

1. Bontis JN, Vavilis DT. (1997) Etiopathology of endometriosis. Ann. NY Acad. Sci. 816: 305-309.
2. Sharpe-Timms KL. (1997) Basic research in endometriosis. Object. Gynecol. Clin. N. Amer. 24: 2, 269-290.
3. Giudice LC. (1994) Growth factors and growth modulations in human uterine endometrium: their potential relevance to reproductive medicine. Fertil. Steril. 61: 1-17.
4. Koutsilieris M, Niklinski W, Frenette G, Lemay A. (1993) Heparin-sepharose binding growth factors in peritoneal fluid of women with endometriosis. Fertil. Steril. 59: 1, 93-97.
5. Koutsilieris M, Akoum A, Lazure C, Frenette G, Lemay A. (1995) N-terminal truncated forms of insulin-like growth factor binding protein-3 in the peritoneal fluid of women without laparoscopic evidence of endometriosis. Fertil. Steril. 63: 2, 314-321.
6. Koutsilieris M, Lavergne E, Lemay A. (1997) Association of protease activity against IGFBP-3 with peritoneal fluid mitogens: possible implications for the ectopic growth of endometrial cells in women with endometriosis. Anticancer Res. 17: 239-244.
7. Koutsilieris M, Frenette G, Lazure C. (1993) Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases. Anticancer Res 13: 481-486.
8. Webber MM, Waghray A. (1995) Urokinase-mediated extracellular matrix degradation and its inhibition by retinoid acid. Clin. Cancer Res. 1: 755-761.
9. Koutsilieris M, Polychronakos C. (1992) Proteolytic activity against IGF-binding proteins involved in paracrine interactions prostate adenocarcinoma cells and osteoblasts. Anticancer Res. 13: 481-486.
10. Giudice LC. (1995) IGF Binding protein-3 protease regulation: how sweet it is! J. Clin. Endocrinol Metab. 80: 2279-2280.
11. Muller HL, Youngman OH, Gargosky SE, Lehrnbecher T, Hintz RL, Rosenfeld RG. (1993) Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis. J. Clin. Endocrinol. Metab. 77: 1113-1119.
12. Matsumoto T, Gargosky SE, Iwasaki K, Rosenfeld RG. (1996) Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. J. Clin. Endocrinol. Metab. 81: 150-155.
13. Lamson G, Giudice LC, Cohen P, Liu F, Gargosky S, Muller HL. (1996) Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo. Growth Reg. 3: 91-95.
14. Reyes-Moreno C, Sourla A, Choki I, Doillon C, Koutsilieris M. (1998) Osteoblast-derived survival factors protect PC-3 human prostate cancer cells from adriamycin-apoptosis. Urology 52: 341-347.
15. Koutsilieris M, Reyes-Moreno C, Choki I, Sourla A, Doillon C, Pavlidis N. (1999) Chemotherapy cytotoxicity of human MCF-7 and MDA-MB 231 breast cells is altered by osteoblast-derived growth factors. Mol. Med. 5: 86-97.
16. Choki I, Sourla A, Reyes-Moreno C, Koutsilieris M. (1998) Osteoblast-derived growth factors enhance adrimycin-cytostasis of MCF-7 human breast cancer cells. Anticancer Res. 18: 4213-4224.
17. Koutsilieris M, Tzanela M, Dimopoulos T. (1999) Novel concept of antisurvival factor (ASF). Therapy produces an objective clinical response on four patients with hormone-refractory prostate cancer: case report. Prostate 38: 313-316.
18. Koutsilieris M, Mitsiades CS, Sourla A. (2000) Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of Prostate cancer cells in osteoblastic metastases: development of anti-survival factor therapy for hormone retractory Prostate cancer. Mol. Med. (In press).
19. Suganuma N, Harada M, Furuhashi M, Nawa A, Kikkawa F. (1997) Apoptosis in human endometrial and endometriotic tissues. Harm. Res. 48: 42-47.
20. Koutsilieris M, Mastrogamvrakis G, Miligos S, et al. (2000) Insulin-like growth factor 1 (IGF-1) is a survival factor protecting KLE endometrial-like cells from programmed cell death. In the program of the XIIth Biennial World Congress on Endometriosis: Endometriosis 2000, London, U.K.,
21. Darzynkiewicz Z, Bruno S, Delbiyo, G. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13: 795-808.
22. Braun DP, Dmowski WP. (1998) Endometriosis. Curr. Opin. Obset. Gynecol. 10: 5, 365-369.
23. Leyendecker G. (2000) Redefining endometriosis: endometriosis is an entity with extreme pleiomorphism. Hum. Reprod. 15: 4-7.
24. Brosens IA, Brosens JJ. (2000) Endometriosis. Hum. Reprod. 15: 1-3.
25. Zeyneloglu HE, Arici A, Olive DL. (1997) Environmental toxins and endometriosis. Obstet. Gynecol. Clin. N. Amer. 24: 2, 307-329.
26. Osteen KG, Sierra P, Rivera E. (1997) Does disruption of immune and endocrine systems by enviroimiental toxins contribute to development of endometriosis? Semin. Reprod. Endocrinol. 15: 3, 301-308.
27. Akoum A, Doillon CJ, Koutsilieris M, et al. (1996) Human endometrial cells in a type I collagen gel. J. Reprod. Med 41: 8, 555-561.
28. Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohí J, Simon C. (1998) The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production. Fertil. Steril. 70: 3, 425-431.
29. Mahnke JL, Dawood MY, Huang JC. (2000) Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil. Steril. 73: 166-170.
30. Bruner KL, Eisenberg E, Gorstein F, Osteen KG. (1999) Progesterone and transforming growth factor-β coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis. Steroids 64: 648-653.
31. Arici A, Seli E, Zeyneloglu HB, Senturk LM, Oral E, Olive DL. (1998) Interleukin-8 induces proliferation of endometrial stromal cells: a potential autocrine growth factor. J. Clin. Endocrinol Metab. 83: 4, 1201-1205.
32. Iwabe T, Harada T, Tsudo T, Tanikawa M, Onohara Y, Terakawa N. (1998) Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis. Fertil. Steril. 69: 924-930.
33. Akoum A, Lermay A, Lajeunesse Y, Marois M, Koutsilieris M. (1999) Immunohistochemical localization of insulin-like growth factor-binding protein-3 in eutopic and ectopic endometrial tissues. Fertil. Steril. 72: 1085-1092.
34. Sbracia M, Zupi E, Alo P, et al. (1997) Differential expression of IGF-I and IGF-II in eutopic and ectopic endometria of women with endometriosis and in women without endometriosis. Am. J. Reprod. Immunol. 37: 326-329.
35. Richer O, Mallmann, P, Van der Ven H, Krebs D. (1998) TNF-α secretion by peritoneal macrophages in endometriosis. Zentralbl. Gynakol. 120: 7, 332-336.
36. Smith SK. (1997) Angiogenesis. Semin. Reprod. Endocrinol. 15: 3, 221-227.
37. Donnez J, Smoes P, Gillerot S, et al. (1998) Vascular endothelial growth factor (VEGF) in endometriosis. Hum. Reprod. 13: 6, 1686-1690.
38. Bruse C, Bergqvist A, Carlstróm K, (1998) Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women. Fertil. Steril. 70: 5, 821-826.
39. Sharpe-Timms KL, Keisler LW, McIntush EW, Keisler DH. (1998) Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy. Fertil. Steril. 69: 1128-1134.
40. Suzumori N, Sato M, Yoneda T, Ozaki Y, Takagi H, Suzumori K. (1999) Expression of secretory leukocyte protease inhibitor in women with endometriosis. Fertil. Steril. 72: 857-867.
41. Gebel HM, Braun DP, Tambur A, Frame D, Rana N, Dmowski WP. (1998) Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil. Steril. 69: 6, 1042-1047.
42. McLaren J, Prentice A, Charnock P, et al. (1997) Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in enodmetriosis. Hum. Reprod. 12: 1, 146-152.
43. Watanabe H, Kanzaki H, Narukawa S, et al. (1997) Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis. Am. J. Obstet. Gynecol. 176: 2, 360-368.
44. Braun DP, Gebel H, Rana N, Dmowski WP. (1998) Cytolysis of eutopic and ectopic endometrial cells by peripheral blood monocytes and peritoneal macrophages in women with endometriosis. Fertil. Steril. 69: 1103-1108.
45. Hendricks DT, Taylor R, Reed M, Binner MJ. (1997) FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res 57: 2112-2115.
46. Borsellino N, Belldegrun A, Bonavida B. (1995) Endogenous interleukin 6 is a resistance factor for cisdiamminedichloroplatinum and etoposide-mediated cytotoxicity of human Prostate carcinoma cell lines. Cancer Res. 55: 4633-4639.
47. Parrizas M, LeRoith D. (1997) Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-x gene product. Endocrinology 138: 1355-1358.
48. Gajewski TF, Thompson CB. (1996) Apoptosis meets signal tranduction: elimination of a BAD influence. Cell 86: 589-592.
49. Zha J, Harada H, Yang E. (1996) Serine phosphorylation of death agoinst Bad in response to survival factor results in binding to 14-3-3 not Bcl-XL. Cell 87: 619-628.